Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

被引：30
|
作者：
Tafazoli, Alireza [1 ,2 ]
Guchelaar, Henk-Jan [3 ,4 ]
Miltyk, Wojciech [1 ]
Kretowski, Adam J. [2 ,5 ]
Swen, Jesse J. [3 ,4 ]
机构：
[1] Med Univ Bialystok, Fac Pharm, Dept Anal & Bioanal Med, Div Lab Med, Bialystok, Poland
[2] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland
[3] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[4] Leiden Network Personalized Therapeut, Leiden, Netherlands
[5] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland
来源：
FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷
基金：
欧盟地平线“2020”;
关键词：
pharmacogenomics; clinical implementation; next generation sequencing; clinical practice; PGx testing; IMPLEMENTATION CONSORTIUM; INCIDENTAL FINDINGS; CYP2D6; DRUG; GENOTYPE; CHALLENGES; EXOME; RECOMMENDATIONS; INFORMATION; MUTATIONS;
D O I：
10.3389/fphar.2021.693453
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy. Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical routines. Next-generation sequencing (NGS) technologies are emerging as a more comprehensive and time- and cost-effective approach in PGx. This review presents the main considerations for applying NGS in guiding drug treatment in clinical practice. It discusses both the advantages and the challenges of implementing NGS-based tests in PGx. Moreover, the limitations of each NGS platform are revealed, and the solutions for setting up and management of these technologies in clinical practice are addressed.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition
    Ku, C. S.
    Cooper, D. N.
    Iacopetta, B.
    Roukos, D. H.
    CLINICAL GENETICS, 2013, 83 (01) : 2 - 6
  • [22] Next-Generation Sequencing
    Le Gallo, Matthieu
    Lozy, Fred
    Bell, Daphne W.
    MOLECULAR GENETICS OF ENDOMETRIAL CARCINOMA, 2017, 943 : 119 - 148
  • [23] Base-calling for next-generation sequencing platforms
    Ledergerber, Christian
    Dessimoz, Christophe
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (05) : 489 - 497
  • [24] The impact of next-generation sequencing on genomics
    Zhang, Jun
    Chiodini, Rod
    Badr, Ahmed
    Zhang, Genfa
    JOURNAL OF GENETICS AND GENOMICS, 2011, 38 (03) : 95 - 109
  • [25] CLINICAL APPLICATIONS OF NEXT-GENERATION SEQUENCING
    Gloria Rebollar-Vega, Rosa
    Arriaga-Canon, Cristian
    Alberto de la Rosa-Velazquez, Inti
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (04): : 153 - 157
  • [26] Next-Generation Sequencing for Clinical Diagnostics
    Jacob, Howard J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (16) : 1557 - 1558
  • [27] Next-Generation Sequencing in Diagnostic Pathology
    Ilyas, Mohammad
    PATHOBIOLOGY, 2017, 84 (06) : 292 - 305
  • [28] Management of Incidental Findings in the Era of Next-generation Sequencing
    Blackburn, Heather L.
    Schroeder, Bradley
    Turner, Clesson
    Shriver, Craig D.
    Ellsworth, Darrell L.
    Ellsworth, Rachel E.
    CURRENT GENOMICS, 2015, 16 (03) : 159 - 174
  • [29] Applying next-generation sequencing to pancreatic cancer treatment
    Mardis, Elaine R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) : 477 - 486
  • [30] Occult Specimen Contamination in Routine Clinical Next-Generation Sequencing Testing
    Sehn, Jennifer K.
    Spencer, David H.
    Pfeifer, John D.
    Bredemeyer, Andrew J.
    Cottrell, Catherine E.
    Abel, Haley J.
    Duncavage, Eric J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (04) : 667 - 674
12345